Agenovir is a leader in the research and development of a novel class of human therapeutics to address diseases associated with, or caused by, latent or persistent viral reservoirs. The individuals affected by these diseases number in the millions, and treatment options are extremely limited or non-existent.
| Website | https://www.agenovir.com/ |
| Revenue | $6.2 million |
| Funding | $10.6 million |
| Employees | 2 (0 on RocketReach) |
| Founded | 2014 |
| Address | 329 Oyster Point Blvd. 3Rd Fl, South San Francisco, California 94080, US |
| Phone | (650) 491-9624 |
| Industry | Biotechnology, Therapeutic Devices, Pharmaceuticals, Healthcare |
| Keywords | Viral Therapeutics, Human Therapeutics, Antiviral Drug Development, Viral Diseases, Therapeutic Development, Infectious Disease Research, Pharmaceutical Research, Drug Discovery, Biotechnology, Drug Development, Life Sciences, Disease Treatment, Medical Research, Clinical Trials, Health Technology |
| Competitors | Roche, Pfizer, The Janssen Pharmaceutical Companies of Johnson & Johnson, AstraZeneca, Novartis, Gilead Sciences, Sanofi, Biogen, GSK, Moderna Therapeutics +48 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Agenovir Corporation employee's phone or email?
Agenovir Corporation Questions
The Agenovir Corporation annual revenue was $6.2 million in 2026.
Agenovir Corporation is based in South San Francisco, California.
The NAICS codes for Agenovir Corporation are [3254, 325, 32].
The SIC codes for Agenovir Corporation are [28, 283].
Related Companies
